纳米材料在治疗血栓的进展
Yetong Shen1,2, Yang Yu1,3, Xin Zhang1
1Department of Biochemistry and Molecular Biology, China Medical University, No. 77 Puhe Road, Shenyang, 110122, China.
Drug delivery and translational research
|November 25, 2023
概括
纳米药物为治疗血栓形成提供了一种有前途的替代药物,用于治疗血栓形成,降低风险和提高有效性. 本综述探讨了用于血栓治疗的纳米医学策略,解决了挑战和未来前景.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 心血管研究研究心血管研究
背景情况:
- 血栓形成是导致死亡和残疾的主要原因,导致血管阻塞和栓塞.
- 传统的血栓抑制药物携带出血并发症的风险和有限的治疗窗口.
- 迫切需要更安全,更有效的血栓瘤治疗策略.
研究的目的:
- 审查纳米药物针对性血栓形成治疗的最新进展.
- 讨论血栓形成,特征和诊断生物标志物.
- 探索新兴的纳米医学策略和血栓形成治疗的未来方向.
主要方法:
- 关于纳米药物在血栓形成治疗中的最新研究的文献综述.
- 对血栓病理生理学和诊断方法的分析.
- 对纳米医药设计和用于血栓治疗的应用进行当前研究的综合.
主要成果:
- 基于纳米材料的药物代表了针对血栓形成的新型生物医学策略.
- 在开发用于血栓诊断和治疗的纳米药物方面取得了令人鼓舞的进展.
- 纳米药物显示出克服传统治疗方法的局限性的潜力.
结论:
- 纳米药物为先进的血栓形成治疗提供了一个有前途的途径.
- 需要进一步的研究来应对纳米医药设计和临床翻译方面的挑战.
- 未来的前景包括改善治疗效果和减少对血栓形成的管理不良影响.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
711
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
711
01:16Clot Retraction and Fibrinolysis
6.2K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.2K